Radiation hygiene in interventional radiology suite
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0
Abstract
Exposure of both patients and medical staff to relatively high doses of radiation is one of the features characteristic of interventional radiology (IR). Regulations regarding this kind of therapeutic management can be found in many legal references and recommendations of European Union Law. The purpose of the paper is collection and systematic analysis of activities and procedures associated with the question of radiation hygiene which should be observed in IR suites. Requirements regarding equipment of the IR suite, as well as radiation protection of patients and medical staff, constitute main questions included in the paper, worked out on the basis of valid regulations and occupational experience of the authors. Particular attention is paid to borderline requirements regarding modern IR suite equipment and its organization. Part of the paper is devoted to the understanding of physical laws of ionizing radiation in biological space and its surroundings. Understanding of physical laws, proper utilization of IR suite equipment, and strict compliance with recommendations of radiation protection by both patients and medical staff are critical for limitation of the harmful influence of radiation during interventional therapeutic procedures. An additional role of the paper is to make it easier to take decisions when creating new IR suites, in accordance with valid regulations and the rule of functionality.
Authors and Affiliations
Jerzy Garcarek, Aleksander Falkowski, Dariusz Janczak, Wacław Weyde
Keywords
Related Articles
- EP ID EP67250
- DOI -
- Views 148
- Downloads 0
Bacteriocins from lactic acid bacteria as an alternative to antibiotics
Bacteriocins are ribosomally synthesized, proteinaceous substances that inhibit the growth of closely related species through numerous mechanisms. The classification system used in this review divided bacteriocins into f...
Inhibitory polimerazy poli(ADP-rybozy) (PARP) w terapii nowotworów z mutacjami BRCA1/2
W obecnie stosowanych terapiach przeciwnowotworowych wykorzystywane są przede wszystkim związki wprowadzające uszkodzenia do DNA. Skuteczność leczenia nowotworów uzależniona jest więc od wydajności mechanizmów związanyc...
Urinary cystatin C as a biomarker of renal tubular injury
Cystatin C (cysC) is an endogenous cysteine peptidase (proteinase) inhibitor that has been intensively investigated as a biomarker of kidney function for many years. It is freely filtered at the kidney glomerulus because...
The hematological malignancies related to primary hypereosinophilia and their diagnostics
Published in 2008, by experts of the World Health Organization, the new classification of hematological malignancies forced a change of look at chromosomal aberrations and gene mutations, which are important in establish...
Pathophysiology and molecular basis of selected metabolic abnormalities in Huntington’s disease
Huntington’s disease (HD) is an incurable, devastating neurodegenerative disease with a known genetic background and autosomally dominant inheritance pattern. HTT gene mutation (mHTT) is associated with polymorphic fragm...